Regencell Bioscience Holdings Limited (NASDAQ:RGC) CEO Yat-Gai Au's holdings dropped 16% in value as a result of the recent pullback
Key Insights Insiders appear to have a vested interest in Regencell Bioscience Holdings' growth, as seen by their...
Stay updated with breaking news from Digital Mobile Venture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Key Insights Insiders appear to have a vested interest in Regencell Bioscience Holdings' growth, as seen by their...
The head of Finfare Inc., an up-and-coming fintech in the Spectrum area of Irvine, has made one of the larger office deals of the year in the area around John Wayne Airport.
/PRNewswire/ -- Acepodia, a clinical stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and...
The company will use the funding to advance its pipeline of off-the-shelf cell therapies, including its lead candidate being studied in HER2-expressing solid tumors.